CME Group Valuation

Is 0HR2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HR2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0HR2 ($229.43) is trading above our estimate of fair value ($226.54)

Significantly Below Fair Value: 0HR2 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HR2?

Key metric: As 0HR2 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0HR2. This is calculated by dividing 0HR2's market cap by their current earnings.
What is 0HR2's PE Ratio?
PE Ratio24.1x
EarningsUS$3.42b
Market CapUS$82.54b

Price to Earnings Ratio vs Peers

How does 0HR2's PE Ratio compare to its peers?

The above table shows the PE ratio for 0HR2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average39.2x
LSEG London Stock Exchange Group
86.6x21.9%UK£59.0b
IHP IntegraFin Holdings
24.4x9.5%UK£1.3b
III 3i Group
8.2x17.7%UK£34.4b
AQX Aquis Exchange
37.5x10.6%UK£186.3m
0HR2 CME Group
24.1x3.1%US$82.5b

Price-To-Earnings vs Peers: 0HR2 is good value based on its Price-To-Earnings Ratio (24.1x) compared to the peer average (39.2x).


Price to Earnings Ratio vs Industry

How does 0HR2's PE Ratio compare vs other companies in the GB Capital Markets Industry?

4 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PNIX Phoenix Digital Assets
1.2xn/aUS$34.29m
IX. i(x) Net Zero
0.1xn/aUS$8.94m
APQ APQ Global
0.4xn/aUS$5.78m
MAFL Mineral & Financial Investments
2xn/aUS$5.00m
No more companies available in this PE range
0HR2 24.1xIndustry Avg. 12.2xNo. of Companies19PE01020304050+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0HR2 is expensive based on its Price-To-Earnings Ratio (24.1x) compared to the UK Capital Markets industry average (12.1x).


Price to Earnings Ratio vs Fair Ratio

What is 0HR2's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HR2 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.1x
Fair PE Ratio22x

Price-To-Earnings vs Fair Ratio: 0HR2 is expensive based on its Price-To-Earnings Ratio (24.1x) compared to the estimated Fair Price-To-Earnings Ratio (22x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HR2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$229.43
US$235.25
+2.5%
9.3%US$275.00US$181.00n/a16
Nov ’25US$224.26
US$235.31
+4.9%
9.3%US$275.00US$181.00n/a16
Oct ’25US$224.19
US$218.00
-2.8%
8.9%US$250.00US$177.00n/a16
Sep ’25US$214.51
US$218.50
+1.9%
8.0%US$250.00US$191.00n/a14
Aug ’25US$197.17
US$218.00
+10.6%
8.3%US$250.00US$191.00n/a14
Jul ’25US$195.41
US$223.80
+14.5%
9.5%US$250.00US$187.00n/a15
Jun ’25US$203.14
US$225.93
+11.2%
8.1%US$250.00US$187.00n/a15
May ’25US$210.51
US$226.27
+7.5%
8.0%US$250.00US$187.00n/a15
Apr ’25US$215.04
US$225.60
+4.9%
8.9%US$250.00US$185.00n/a15
Mar ’25US$218.58
US$225.67
+3.2%
8.8%US$250.00US$185.00n/a15
Feb ’25US$206.08
US$221.87
+7.7%
9.5%US$250.00US$180.00n/a15
Jan ’25US$209.47
US$228.01
+8.9%
8.4%US$250.00US$180.00n/a15
Dec ’24US$220.68
US$227.53
+3.1%
8.5%US$250.00US$180.00n/a15
Nov ’24US$212.50
US$227.40
+7.0%
8.5%US$250.00US$180.00US$224.2615
Oct ’24US$200.06
US$213.25
+6.6%
8.6%US$250.00US$173.00US$224.1914
Sep ’24US$202.45
US$210.50
+4.0%
10.4%US$250.00US$167.00US$214.5114
Aug ’24US$199.39
US$213.44
+7.0%
10.8%US$254.00US$167.00US$197.1716
Jul ’24US$184.55
US$206.47
+11.9%
11.0%US$250.00US$160.00US$195.4115
Jun ’24US$179.35
US$205.43
+14.5%
11.5%US$250.00US$160.00US$203.1414
May ’24US$184.66
US$205.86
+11.5%
11.4%US$250.00US$160.00US$210.5114
Apr ’24US$189.95
US$205.75
+8.3%
11.0%US$250.00US$160.00US$215.0416
Mar ’24US$184.26
US$205.00
+11.3%
11.3%US$250.00US$160.00US$218.5816
Feb ’24US$176.89
US$201.47
+13.9%
11.7%US$250.00US$159.00US$206.0816
Jan ’24US$168.37
US$207.55
+23.3%
10.8%US$250.00US$161.00US$209.4717
Dec ’23US$178.13
US$209.35
+17.5%
11.9%US$270.00US$161.00US$220.6817
Nov ’23US$172.49
US$209.71
+21.6%
12.0%US$270.00US$161.00US$212.5017

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies